Navigation Links
Apelon Announces Availability of New TermManager® Software
Date:10/24/2011

RIDGEFIELD, Conn., Oct. 24, 2011 /PRNewswire/ -- Apelon, Inc., a leading provider of terminology and data interoperability solutions, today announced the availability of the first comprehensive, cloud-based terminology mapping solution. TermManager, a code set management and collaborative mapping application, cost-effectively supports healthcare data interoperability initiatives by enabling widespread access to national healthcare vocabulary standards including SNOMED CT®, LOINC®, ICD, RxNorm and NDF-RT. Using TermManager, individuals and organizations can map legacy information to required standards for Meaningful Use incentive payments, departmental data consolidation and regional integration. TermManager is today's answer to the mission-critical data interoperability needs of health systems.

Easy to use, TermManager is a virtual application that can be accessed by anyone with a web browser to manage sets of local terms and map them to national data standards. For instance, a lab manager can map local laboratory test names to LOINC concepts, or a medical records specialist can map their problem list to SNOMED CT. No infrastructure purchase is required, and flexible licensing terms are available facilitating widespread adoption and encouraging greater use of mapping for terminology normalization.

"Mapping local terms to national and international standards is a fundamental requirement for healthcare data to be comparable and interoperable," said Stephen Coady, Apelon's President and CEO.  "By innovating the distribution model for TermManager, Apelon is further supporting the needs of data standardization and interoperability in Electronic Medical Records systems and Healthcare Information Exchanges. TermManager will enable Accountable Care Organizations, hospitals, laboratories, EMR vendors and decision support companies alike, to standardize and manage their data sets, leading to more accurate and comparable reporting, identification of best proven practices and reduction of practice variation."

TermManager maintains local code sets and the latest versions of industry standard code systems, including Meaningful Use subsets, in a secure infrastructure with around-the-clock access by registered users. Accurate, up-to-date mappings are assured through the use of Apelon's proven TermWorks matching technology, and role-based access control is available with flexible workflow processes for review and approval.  An additional product differentiator is the unique capability for users to view map results made by other members of the TermManager community, further enhancing learning and increasing map development efficiency.

For further information about TermManager, visit www.Apelon.com/TermManager

About Apelon

Apelon is an international clinical informatics company focusing on data standardization and interoperability. Apelon software and professional services helps leading healthcare enterprises, life sciences organizations and government agencies improve the quality, comparability and accessibility of their information.  Visit www.Apelon.com for additional information.

TermManager is a registered trademark of Apelon, Inc.


'/>"/>
SOURCE Apelon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
Breaking Medicine News(10 mins):